Applied Nutrition, based in Liverpool, plans to launch a £500m IPO, marking a significant event on the London Stock Exchange for this year.
- The company has recorded notable growth in the last 12 months leading up to July, underpinning their decision to go public.
- The IPO will consist exclusively of existing shares sold by current shareholders, targeting institutional investors in the UK and retail investors via the Retail Book platform.
- Significant appointments to the leadership team have been made in preparation for this listing, with notable figures such as AJ Bell founder Andy Bell taking key roles.
- This IPO is set against the backdrop of reduced new listings on the London Stock Exchange, highlighting its potential importance.
Applied Nutrition, a company headquartered in Liverpool, has announced its intention to initiate a substantial £500m Initial Public Offering (IPO) on the London Stock Exchange, expected to be completed by October. This development represents one of the most noteworthy listings of the year.
Over the past year, the company has achieved remarkable growth, culminating in their decision to proceed with the listing. In August, it disclosed plans for this significant IPO, which underscores its strategic ambitions amidst a challenging economic environment.
The offering will exclusively involve existing shares held by the current shareholders, aimed primarily at institutional investors within the United Kingdom. Additionally, retail investors can access shares through the Retail Book platform. Post listing, the company aims to achieve a free float of no less than 25 per cent. “Any additional details in relation to the offer, together with any changes to corporate governance arrangements, will be disclosed in a prospectus, if and when published,” the company has declared.
In a move to reinforce its strategic leadership, Applied Nutrition has fortified its senior team by appointing key industry figures ahead of the IPO. AJ Bell founder Andy Bell has assumed the position of chair, alongside Tony Buffin, formerly the leader of Holland & Barrett, and Marnie Millard, ex-chief executive of Nichols, as non-executive directors.
The significance of this IPO is further accentuated by the declining number of new listings on the London Stock Exchange, with only 23 companies enlisting last year, down from 45 in the previous year. This context highlights the potential impact of Applied Nutrition’s forthcoming public offering.
The upcoming IPO underscores Applied Nutrition’s strategic growth and its potential impact on the London Stock Exchange.
